AnGesMG, Inc.

City:

Osaka

Country:

Japan

Published Applications:

Last publication date:

2016-10-20

Patent Grants:

Last grant date:

2018-03-13

Top Inventors for applications by AnGesMG, Inc.

These are the the leading inventors for applications assigned to AnGesMG, Inc.:

Ryuichi MORISHITA 2 Osaka, Japan
MASAYUKI FUKUMURA 1 OSAKA, Japan
Yoshiaki TANIYAMA 1 Osaka, Japan
Hiroshi KORIYAMA 1 Osaka, Japan

Hironori Nakagami 1 Ibaraki, Japan
Hidetoshi Hamamoto 1 Kagawa, Japan
Hiroshi Koriyama 1 Ibaraki, Japan
Futoshi Nakagami 1 Ibaraki, Japan

Tatsuro Nakano 1 Kagawa, Japan
Hirokazu Kawano 1 Osaka, Japan
Kazuya Shinohara 1 Kagawa, Japan
Toshio Ogihara 1 Osaka, Japan

Ryuichi Morishita 1 Ibaraki, Japan
Masayasu Okochi 1 Kyoto, Japan
Naoyuki Sato 1 Hyogo, Japan
Futoshi NAKAGAMI 1 Osaka, Japan

Makoto Sakaguchi 1 Osaka, Japan
Mariko Kyutoku 1 Ibaraki, Japan
Masayuki Kurooka 1 Osaka, Japan
Mariko KYUTOKU 1 Osaka, Japan

Yasufumi Kaneda 1 Osaka, Japan
Katsunori Kobayashi 1 Kagawa, Japan
Hironori NAKAGAMI 1 Osaka, Japan
Hitoshi Kotani 1 Hyogo, Japan

Recent patent applications by AnGesMG, Inc.

AnGesMG, Inc. based in Osaka, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2016-10-20 ✅ Patent 9,913,886 granted on 2018-03-13

US20160303211A1

Human necessities

DNA vaccine containing specific epitope of apolipoprotein (a)

#2 | 2016-03-31

US20160090600A1

Chemistry; metallurgy

COMPOSITION FOR EXTERNAL APPLICATION COMPRISING TRANSCRIPTION FACTOR DECOY AS ACTIVE INGREDIENT

#3 | 2009-04-02

US20090087916A1

Physics

Assay method for identifying drug candidate

#4 | 2008-09-18 ✅ Patent 7,871,765 granted on 2011-01-18

US20080226674A1

Human necessities

Composition having antitumor effect

AssigneeID:

106751 ⎘